The same diagnosis can contain different pathways
Two people with similar kidney function may have different inherited risks, biological activity, environmental exposures and rates of progression.
Routine clinical variables remain essential, but they may not fully explain why one person remains stable while another experiences rapid decline.
Multiple evidence layers can be tested together
Deep phenotyping connects routine clinical measurements with biomarkers, genomics, vascular and retinal imaging, environmental information and digital monitoring.
The scientific value comes from testing whether these layers add reliable information beyond established clinical factors, not from collecting complexity for its own sake.
Translation requires disciplined validation
Any proposed signature or prediction model should be assessed for discrimination, calibration, reproducibility and performance across relevant groups.
Transparent modelling and longitudinal outcomes are necessary before a research signal can be considered useful for future clinical studies.